Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/c2/c8/f7/c2c8f770-fb9f-b5f3-ea9e-1a7f4c522297/mza_11131086705888817192.jpg/600x600bb.jpg
Decera Clinical Education Pharmacy Practice Podcast
ProCE
23 episodes
2 days ago
Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.
Show more...
Courses
Education,
Health & Fitness,
Medicine,
Science,
Life Sciences
RSS
All content for Decera Clinical Education Pharmacy Practice Podcast is the property of ProCE and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.
Show more...
Courses
Education,
Health & Fitness,
Medicine,
Science,
Life Sciences
https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/5f4209c7-304e-42e2-bddf-d79c8377f51d/3000x3000/pod409-ckd-in-t2dm-apha-podcast-icon.jpg?aid=rss_feed
Pearls on the Role of Mineralocorticoid Receptor Antagonists and the Impact on Patient Care in CKD in T2D
Decera Clinical Education Pharmacy Practice Podcast
29 minutes 14 seconds
3 years ago
Pearls on the Role of Mineralocorticoid Receptor Antagonists and the Impact on Patient Care in CKD in T2D
Drs Diana Isaacs and Joshua J. Neumiller summarize key information on the evidence behind the use of finerenone in diabetic kidney disease, selecting appropriate patients for finerenone therapy, and the role of the pharmacist in caring for these patients.
Decera Clinical Education Pharmacy Practice Podcast
Enhance your pharmacy practice with ProCE’s up-to-date, clinically relevant, and evidence-based education across a variety of therapeutic areas.